Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results

Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results

Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, February 4, 2026, at 8:00 a.m. CST to review its second quarter fiscal 2026 financial results.

Access to the discussion may be obtained as follows:

Time:

8:00 a.m. CST

Date:

February 4, 2026

Dial-in: 

1-800-579-2543 or 1-785-424-1789 (for international callers)

Conference ID:

TECHQ2

Webcast:

https://investors.bio-techne.com/ir-calendar

A recorded rebroadcast will be available for interested parties unable to participate in the live conference call by dialing 1-844-512-2921 or 1-412-317-6671 (for international callers) and referencing Conference ID 11160826.

The replay will be available from 11:00 a.m. CST on Wednesday, February 4, 2026, until 11:00 p.m. CST on Wednesday, March 4, 2026.

About Bio-Techne
Bio-Techne Corporation (NASDAQ: TECH) is a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities. Bio-Techne products assist scientific investigations into biological processes and the nature and progress of specific diseases. They aid in drug discovery efforts and provide the means for accurate clinical tests and diagnoses. With hundreds of thousands of products in its portfolio, Bio-Techne generated over $1.2 billion in net sales in fiscal 2025 and has approximately 3,100 employees worldwide. For more information on Bio-Techne and its brands, please visit https://www.bio-techne.com or follow the Company on social media at LinkedIn, X, or YouTube. 

Contact: 

David Clair, Vice President, Investor Relations


david.clair@bio-techne.com


612-656-4416

BT Logo (PRNewsfoto/Bio-Techne Corporation)

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/bio-techne-to-host-conference-call-on-february-4-2026-to-announce-second-quarter-fiscal-2026-financial-results-302663784.html

SOURCE Bio-Techne Corporation

News Provided by PR Newswire via QuoteMedia

TECH
The Conversation (0)
Western Uranium & Vanadium Provides Update on Mill License Application

Western Uranium & Vanadium Provides Update on Mill License Application

July 14, 2026 Western Uranium & Vanadium Corp. (CSE: WUC,OTC:WSTRF) (OTCQX: WSTRF) ("Western" or the "Company") is pleased to provide an update on its progress toward submitting the radioactive materials license application for the Mustang Mineral Processing Plant ("Mustang"), located at the... Keep Reading...
SAGA Metals Completes Acquisition of Wolverine Heavy Rare Earth Element Project in Labrador-REE Mineralized Potential Similar to Strange Lake and Tanbreez

SAGA Metals Completes Acquisition of Wolverine Heavy Rare Earth Element Project in Labrador-REE Mineralized Potential Similar to Strange Lake and Tanbreez

Saga Metals Corp. (TSXV: SAGA,OTC:SAGMF) (OTCQB: SAGMF) (FSE: 20H) ("SAGA" or the "Company"), a North American exploration company focused on critical mineral discoveries, is pleased to announce that, further to its news release dated April 14, 2026, it has closed the previously announced... Keep Reading...
Homerun Resources Inc. Confirms Optimized +4N Purification Plant Pathway and Advances CAPEX Configurations for the SME High-Purity Silica

Homerun Resources Inc. Confirms Optimized +4N Purification Plant Pathway and Advances CAPEX Configurations for the SME High-Purity Silica

Homerun Resources Inc. (TSXV: HMR,OTC:HMRFF) (OTCQB: HMRFF) ("Homerun" or the "Company") is pleased to provide an update on Phase 2 of its Three-Phase Integrated Purification Platform for the Santa Maria Eterna ("SME") silica sand district in Belmonte, Bahia, Brazil, following completion of the... Keep Reading...
Lexaria Updates Business Development

Lexaria Updates Business Development

KELOWNA, BC / ACCESS Newswire / July 6, 2026 / Lexaria Bioscience Corp. (NASDAQ:LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to have experienced many positive meetings with potential pharmaceutical partners and collaborators at the 2026 BIO... Keep Reading...
Lexaria Updates Business Development

Lexaria Updates Business Development

(TheNewswire) Kelowna, British Columbia July 6, 2026 TheNewswire Lexaria Bioscience Corp. (Nasdaq: LEXX) (the "Company" or "Lexaria"), a global innovator in drug delivery platforms, is pleased to have experienced many positive meetings with potential pharmaceutical partners and collaborators at... Keep Reading...

Interactive Chart

Latest Press Releases

Related News